|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-6-2
|
|
pubmed:abstractText |
Soft tissue sarcomas comprise a heterogeneous group of malignancies of mesenchymal origin. Although sarcomas can arise virtually anywhere, the most common primary site is the extremity. The development of metastatic disease poses a major clinical problem because it is seldom amenable to a curative treatment. However, with careful and expert multidisciplinary team selection of patients with metastatic sarcoma-balancing probability of benefit with certain toxicity-a combined multimodality approach may provide hope to a select few for prolonged survival and even cure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0039-6109
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
661-72, viii
|
|
pubmed:meshHeading |
pubmed-meshheading:18514705-Antineoplastic Agents, Alkylating,
pubmed-meshheading:18514705-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18514705-Combined Modality Therapy,
pubmed-meshheading:18514705-Dacarbazine,
pubmed-meshheading:18514705-Doxorubicin,
pubmed-meshheading:18514705-Humans,
pubmed-meshheading:18514705-Ifosfamide,
pubmed-meshheading:18514705-Lung Neoplasms,
pubmed-meshheading:18514705-Mesna,
pubmed-meshheading:18514705-Sarcoma,
pubmed-meshheading:18514705-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Multidisciplinary management of metastatic sarcoma.
|
|
pubmed:affiliation |
Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. kthornt2@jhmi.edu
|
|
pubmed:publicationType |
Journal Article,
Review
|
